Back to search

Article

Inhibitory effects of aviptadil on the SARS-CoV-2 nsp10/ nsp16 protein complex

2021-02-16

Abstract excerpt

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which emerged in late 2019, causes COVID-19, a disease that has been spreading rapidly worldwide. In human lung epithelial cells and monocytes, RLF-100 (aviptadil) has been found to inhibit the RNA replication machinery of SARS-CoV-2, which includes several non-structural proteins (nsp) that play essential roles in synthesizing and replicating viral RNA...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b121f561-f35f-53b3-ba7f-f152358cdaef
DOI
10.21203/rs.3.rs-191980/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Inhibitory effects of aviptadil on the SARS-CoV-2 nsp10/ nsp16 protein complexDOI 10.21203/rs.3.rs-191980/v1
Select a neighboring publication to make it the new centre.